Skip to main content


Generic name: somapacitan-beco
Dosage form: injection, for subcutaneous use
Drug class: Growth hormones

Medically reviewed by Judith Stewart, BPharm. Last updated on Jul 18, 2023.

What is Sogroya?

Sogroya is a prescription medicine that is used to treat people with growth hormone deficiency.

Sogroya is given by injection under the skin (subcutaneous) to replace growth hormones that are normally produced in the body.

What is Sogroya used to treat?

Sogroya is used to treat adults with growth hormone deficiency.

Sogroya is also used to treat growth failure due to inadequate secretion of endogenous growth hormone in children aged 2.5 years and older.

Who should not use Sogroya?

You should not use Sogroya if:

Before taking Sogroya

Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:


Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby.


Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if this medicine passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya while you breastfeed.

What other drugs will affect Sogroya?

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Sogroya may affect how other medicines work, and other medicines may affect how Sogroya works.

How should I use Sogroya?

Sogroya side effects

Sogroya may cause serious side effects, including:

The most common side effects in adults include:

The most common side effects in children include:

These are not all the possible side effects.Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

You may also report side effects to Novo Nordisk at 1-888-668-6444.

How should I store Sogroya?

Before you use Sogroya pens for the first time:

After you use Sogroya pens and there is still medicine left:

Keep medicines out of the reach of children and pets.

General information about the safe and effective use of Sogroya.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use this medicine for a condition for which it was not prescribed. Do not give it to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information that is written for health professionals.

What are the ingredients in Sogroya?

Active ingredient: somapacitan-beco
Inactive ingredients: histidine, mannitol, phenol, poloxamer 188, Water for Injection, and hydrochloric acid and sodium hydroxide (as needed)

Instructions for Use

Step 1. Prepare your Sogroya Pen

Always use a new needle for each injection. This reduces the risk of contamination, infection, leakage of Sogroya, and blocked needles leading to incorrect dosing.

Step 2. Check the Sogroya flow with each new Pen

If your Pen is already in use, go to Step 3.

If no Sogroya appears, repeat Step 2 up to 6 times.

If you still do not see a drop of Sogroya, change the needle:

Do not use the Pen if a drop of Sogroya still does not appear after changing the needle and repeating Step 2. Call Novo Nordisk at 1-888-668-6444
for help.

Step 3. Select your dose

If there is not enough Sogroya left to select a full dose, see Frequently Asked Questions.

The dose counter shows the dose in “mg”. Always use the dose counter to select the exact dose. Do not use the “click” sounds you hear when you turn the dose selector to select your dose. Only the dose pointer on the dose counter will show the exact dose selected.

If you select the wrong dose, you can turn the dose selector clockwise or counterclockwise to the correct dose.
The Pen “clicks” sound and feel differently when the dose selector is turned clockwise, counterclockwise, or if you forcefully move it past the number of “mg” left in the Pen.

Step 4. Inject your dose

You may see a drop of Sogroya at the needle tip after injecting. This is normal and does not affect your dose.

Step 5. After your injection

Always throw away (dispose of) the needle after each injection.
For further information about safe sharps disposal, see Frequently Asked Questions.
Do not try to put the needle cap back on. You may stick yourself with the needle.

See How should I store Sogroya?

Frequently Asked Questions

How do I see how much Sogroya is left in my Pen?
The Pen scale shows you approximately how much Sogroya is left in your Pen. To see how much Sogroya is left in your Pen, use the dose counter:
Turn the dose selector clockwise until the dose counter stops. The dose pointer will line up with the number of “mg” left in the Pen. You can select a maximum dose of 4.0 mg. If the dose counter stops with the dose pointer lined up with “4.0”, at least 4.0 mg are left in your Pen. If the dose counter stops with the dose
pointer lined up with “2.8”, only 2.8 mg are left in your Pen.

What if I need a larger dose than what is left in my Pen?
It is not possible to select a larger dose on the dose counter than the number of “mg” left in your Pen. If you need more Sogroya than you have left in your Pen, you can use a new Pen or split your dose between your current Pen and a new Pen. Only split your dose if you have been trained or advised by your healthcare provider on how to do this. You may find it helpful to use a calculator to plan the doses as instructed by your healthcare provider.

Be very careful to calculate your split dose correctly so that you do not give the wrong dose. If you are not sure how to split your dose using 2 Pens, then select and inject the dose you need with a new Pen.

What if no Sogroya appears when I check the flow?
A. Your needle may be blocked or damaged, if no Sogroya appears at the needle tip. Remove the needle as described in Step 5 and repeat Step 1 and Step 2.
B. Your Pen may be defective, if Sogroya still does not appear after changing the needle. Do not use the Pen. Contact Novo Nordisk at 1-888-668-6444.

What if “0” does not appear after completing my injection?
The needle may be blocked or damaged, and you have not received any Sogroya, even though the dose counter has moved from the dose that you have set. Remove the needle as described in Step 5 and repeat Step 1 to Step 4.

How should I take care of my Pen?
Be careful not to drop your Pen or knock it against hard surfaces. Do not expose your Pen to dust, dirt, liquid, or direct light. See How should I store Sogroya? Do not try to refill your Pen, it is prefilled.

What if I drop my Pen?
If you drop your Pen or think that something is wrong with it, attach a new disposable needle and check the Sogroya flow before you inject (See Step 1 and Step 2). Do not try to repair your Pen or pull it apart.

How do I clean my Pen?
Do not wash, soak, or lubricate your Pen. If necessary, clean it with mild detergent on a moistened cloth.

How do I throw away (dispose of) used Sogroya needles and Pens?
Put your used needles and Pens in an FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) loose needles and Pens in your household trash. If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:

When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should dispose of used needles and Pens. For more information about safe sharps disposal, and for specific information about safe sharps disposal in the state that you live in, go to the FDA’s website at: Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.

Important information

Caregivers must be very careful when handling needles to reduce the risk of needle sticks and infection.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.